Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. MTCH
10. CVI

Go back to Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q1 EPS by 23c, Revenues Beat

May 6, 2021 7:51 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q1 EPS of ($0.23), $0.23 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $4.83 million versus the consensus estimate of $2.67 million.

First Quarter 2021 Financial Results

Revenues were $4.8 million for the first quarter of 2021, consisting of $4.0 million in revenue recognized under Syros collaboration with Global Blood Therapeutics, Inc. (GBT) and $0.8 million recognized under its collaboration with Incyte Corporation (Incyte). Syros recognized $2.4 million in revenue in the first quarter of 2020, including $2.2 million under its collaboration with GBT and $0.2 million under its collaboration with Incyte.Research and... More